date:Feb 27, 2014
s expansive reliance on professional judgment calls. While professional judgment may be a necessary part of safety determinations, some suggest FDA should also update its review process. For instance, Pew has suggested that FDA update its science, require companies to submit GRAS notifications, and implement a systematic review process for existing GRAS substances.
And FDAs expansive reliance on professional judgment compounds conflicts of interest issues as well, according to Neltner.
When a